ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Cesarean Scar Pregnancy and Subsequent Obstetric Outcomes: Focus on Postpartum Hemorrhage and Predictive Factors.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Cesarean scar pregnancy (CSP), a rare form of ectopic pregnancy, is associated with substantial maternal morbidity and uncertain implications for subsequent pregnancies. This study evaluated the association between prior CSP and adverse obstetric outcomes in subsequent pregnancies; it also explored independent predictors of postpartum hemorrhage (PPH). MATERIAL AND METHODS This retrospective single-center study included 15 439 women with prior cesarean section who delivered at a tertiary hospital (January 2015 to December 2023): 83 patients with CSP (Type I: n=24, ultrasound-guided uterine aspiration; Type II/III: n=59, uterine artery embolization [UAE]+aspiration) and 15 356 patients without CSP (non-CSP). Outcomes included PPH and secondary obstetric and neonatal complications. Multivariate logistic regression analysis was performed to address potential confounders. RESULTS CSP was associated with higher rates of PPH (21.7% vs 1.7%; adjusted relative risk [aRR] 2.62, P=0.024), placenta previa (aRR 6.50, P<0.001), placenta accreta spectrum (PAS; aRR 8.31, P<0.001), preterm delivery before 33 weeks (aRR 12.05, P<0.001), and low birth weight (aRR 4.19, P<0.001). Type II/III CSP (adjusted odds ratio [aOR] 17.90, P<0.001), placenta previa (aOR 5.12, P=0.046), and PAS (aOR 12.48, P<0.001) were independent predictors of PPH. UAE did not significantly affect PPH risk (P=0.628). CONCLUSIONS CSP increases the risk of adverse obstetric outcomes. Type II/III CSP, placenta previa, and PAS are predictors of PPH. Prenatal assessments of CSP recurrence and placental disorders are critical for maternal-fetal safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.